Research programme: viral vaccines - CPL BiologicalsAlternative Names: Recombinant nanoparticle vaccines - CPL Biologicals
Latest Information Update: 20 May 2014
At a glance
- Originator CPL Biologicals
- Class Protein-vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Rabies
- Research Unspecified